Approval · Notice of Compliance 3389 · 2003
FEMHRT: Notice of Compliance 3389
Issued June 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3389
- Date
- June 14, 2003
- Company
- Galen (Chemicals) Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Estrogen-progestin combination
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FEMHRT | 02242530 | — |
| FEMHRT | 02242531 | Cancelled Post Market |
Medicinal ingredients
- ETHINYL ESTRADIOL 2.5 MCG per TAB
- NORETHINDRONE ACETATE 0.5 MG per TAB
- ETHINYL ESTRADIOL 5 MCG per TAB
- NORETHINDRONE ACETATE 1 MG per TAB